2016
Dr. Seth Berkley, CEO, GAVI Alliance
"India is a prime example of how the vaccine landscape has changed over the past 20 years. Indian manufacturers can produce vaccines that meet high quality standards, are appropriate to specific country settings, and are offered at lower and sustainable prices through a reliable supply over time. They also have the capacity to engage in applied vaccine development. I am excited at the prospect of seeing Indian manufacturers develop new combination vaccines as well as tackling new diseases that are especially relevant to those living in developing countries."
Dr. Krishna M. Ella, CMD, Bharat Biotech International Ltd., Hyderabad
"BioAsia over the years has been instrumental in showcasing the Lifesciences and R&D strengths of Hyderabad and Andhra Pradesh to the world particularly the presence of Genome Valley – the largest industrial cluster in country. India is an excellent destination for Biotech/Biopharma industries. Hyderabad is the biggest manufacturer of biotech products and vaccines in the country and this explains the focus of BioAsia on elements like policy, strategy and markets"
Dr. K V Balasubramaniam, Managing Director, Indian Immunologicals Ltd.
"More professionally conducted this time with better industry participation"
2012
Shri N Kiran Kumar Reddy, Hon'ble Chief Minister of Andhra Pradesh
"Biotech companies have a crucial role in the society and will have to keep the quality and affordability of medicines in mind. India is amongst the top 12 biotech destinations in the world and second in Asia, after China. I am glad that the state of Andhra Pradesh has emerged as the undisputed leader in the country for Biotechnology and BioAsia has been a great platform helping the Government in attracting new investments into the state and showcasing the strengths of Genome Valley to the global community. I take this opportunity to assure continued support from the Government to the development of sector"
Dr. (Smt.) J. Geeta Reddy, the Hon'ble Minister for Major Industries, Sugar, Commerce & Export Promotion, Govt. Of Andhra Pradesh
"BioAsia has been successful in significantly contributing towards development of biotechnology industry in India in general and in particular in Andhra Pradesh over the least eight years. Focusing on vaccines, the ninth edition of BioAsia has been successful in assembling the key stakeholders of the sector both globally and from India. Prominent participation of the Indian vaccine manufacturers like Bharat Biotech International, Shantha Biotech, Serum Institute of India, Panacea Biotech, Biological E, Indian Immunologicals Ltd, in the event highlights of the importance of the event."
Dr. Seth Berkley, CEO, GAVI Alliance
"India is a prime example of how the vaccine landscape has changed over the past 20 years. Indian manufacturers can produce vaccines that meet high quality standards, are appropriate to specific country settings, and are offered at lower and sustainable prices through a reliable supply over time. They also have the capacity to engage in applied vaccine development. I am excited at the prospect of seeing Indian manufacturers develop new combination vaccines as well as tackling new diseases that are especially relevant to those living in developing countries."
Dr. KV Raghavan, VP, FABA
"Indian Biotech industry had crossed over 3$ billion in 2010-2011 and BioAsia is an integral part of the Biotech industry's growth."
Dr. Krishna M. Ella, CMD, Bharat Biotech International Ltd., Hyderabad
"BioAsia over the years has been instrumental in showcasing the Lifesciences and R&D strengths of Hyderabad and Andhra Pradesh to the world particularly the presence of Genome Valley – the largest industrial cluster in country. India is an excellent destination for Biotech/Biopharma industries. Hyderabad is the biggest manufacturer of biotech products and vaccines in the country and this explains the focus of BioAsia on elements like policy, strategy and markets"
Vishal Gandhi, SVP and Head- Life Sciences, Yes Bank
"It was a truly a vibrant platform and discussions were very stimulating clearly suggesting a road map to take the Indian biotech industry to next level of growth."
Roopesh Bhargava, Director - Sales & Marketing, Sanofi Pasteur India (Pvt) Ltd., Mumbai
"It was indeed a pleasure attending the BioAsia 2012 at Hyderabad. It was a very well thought off coordinated effort to put such a conference. My personal compliments to the team. The Agenda and the subject was very well chosen"
Dr. Shreemanta K Parida, CEO, Vaccine Grand Challenge Program, Dept of Biotechnology, Ministry of Science & Technology, Govt. of India
"I commend BioAsia2012 organisers for making an effort to bring various stakeholders around the table in a breakfast meeting with Seth Berkley, GAVI Chair as the top of the table. It was gratifying to see the vibrance, enthusiasm and commitments across all sectors to take the vaccine agenda forward cohesively. The most touching part of that meeting is the bold openness of many who raised pertinent issues about our shortfalls and weaknesses. This reflects the turning point and the paradigm shift at "looking at the half empty" glass to dream to fill it up. If we can dream it, we can make it. Yes, we can! This is the beginning and we need to create a cohesive community and ecosystem for everyone to echo their voice as well as to put their one cent keeping the bigger picture as the ultimate objective knocking down all the barriers on the way.
On the concluding point, we need to aim Vaccines - not as "A Shot in the Arm!" in 2012, but as "Lollipop in the mouth!""
Dr. Harish Iyer, CEO, Shantha Biotech, Hyderabad
"This was an excellent meeting with topics discussed being clearly relevant to vaccines and expanding use for improvement of public health"
Mr. Manni Kantipudi, Chief Executive Officer, GVK Biosciences
"The BioAsia 2012 was well organized, had good speakers and was well attended. The focus on CROs was important for HYDERABAD to project".
Dr. K V Balasubramaniam, Managing Director, Indian Immunologicals Ltd.
"More professionally conducted this time with better industry participation"
Mr. Karikal Valaven, IAS, Convener, BioAsia 2012
"The precise number of registered delegates for the event was 598; in addition over 450 visitors also thronged the three-day global bio-business event. Sri Lanka participated as the Country Partner for the event and more than 40 countries took part in BioAsia 2012 with major delegations from USA, Korea, Belgium, Pennsylvania, Germany, Iran, Singapore, Nepal and Africa. The international tradeshow at BioAsia 2012 attracted about 75 Companies from across the globe wherein the Biobazaar (International Buyer Seller Meet) had over 45 sponsored international buyers from 17 Countries. We are extremely grateful for the support received from the Government of India through Department of Biotechnology, Department of Pharmaceuticals, Department of Commerce, Department of Science & Technology etc."
Dr. Krishna Ella, Chairman and Managing Director, Bharat Biotech International Ltd.
"Over the years, BioAsia has become an industry oriented event while the Bangalore India Bio event has remained research oriented. Hyderabad is the biggest manufacturer of biotech products and vaccines in the country and this explains the focus of BioAsia on elements like strategy and markets while the Bangalore event is focused on research"
Dr. Richard Connell, Vice President and Head of Asia Research, Pfizer, Shanghai
"There were some interesting discussions and it was good to meet business partners at the location. The logistics (layout of rooms, food, location) were all very comfortable."
Mr. Sai D. Prasad, VP – Business Development, Bharat Biotech International Ltd.
"BioAsia 2012 was well organized."
Dr. Roger L. Williams, CEO, US Pharmacopeia, Rockville, Maryland, USA
It was indeed my privilege and pleasure to present the keynote address at the Inaugural Ceremony at BioAsia 2011. I thank the BioAsia team very kindly for the Special Award. It is currently displayed in a highly visible place of honor at the United States Pharmacopeia's (USP) headquarters in Rockville, Maryland.
Mr. Qin Hongming, First Secretary, Chinese Embassy, New Delhi
BioAsia 2011 is my great memorable experience in India. The venue condition, the efficiency of the Secretariat, the reception and the accommodation, everything is international level and excellent. I thank you for your kind and hospitable reception during the forum. I hope we could get more cooperation in future.
Dr. Ravi Vinayak, Qiagen- Point of Need Devices-OEM , USA
It was a pleasure being part of Bioasia and we would be delighted to come back again
Dr. Arvind Mahajan, The Roslin Institute, University of Edinburgh, U.K.
I like to express my thanks for the opportunity I had to speak at the BioAsia2011. BioAsia - 2011 provided an excellent platform to meet some leading scientists working in the field of human and animal health. The visit to Genome Valley was one of the highlights of BioAsia 2011 -it was a perfect showcase occasion to give a feel of ongoing developments in Bio-Pharma in India. I shall look forward to BioAsia 2012 with a keen interest.
Dr. Arvind Kapur, CEO, Rasi Seeds, India
Bio Asia 2011 is a good platform to exchange information and ideas with different stakeholders in Biotechnology research and product development. My experience of last two years attending this event is very good.
Mr. Lukas Utiger, Head Lonza Biosciences, Walkersville, USA
Many thanks for the kind words. I thoroughly enjoyed my time at BioAsia.
Dr. Ganesh Kishore, CEO of Malaysian Government Investment Branch, Malaysia
Many thanks for inviting me to participate in a great meeting and I congratulate you on pulling together this excellent meeting. Besides the great diversity and richness of topics and participation of people with in depth knowledge of the field, it was also great to see many young minds during the conference.
Dr. Fernando de Mora, SALUPHARMA BIOSIMILARS SA and Chairman / Department of Pharmacology, Therapeutics and Toxicology (Edificio V) Universitat Autònoma de Barcelona, Spain
I think it was a most interesting opportunity to meet Indian companies and promote exchange and partnerships with our and other corporations.
Dr. Arvind Kapur, RAASI Seeds, Tamil Nadu
I really enjoyed the discussions and presentations in Bio Asia 2010. In the Agricultural biotechnology forum we had very lively and intensive discussions on the trivial issues presently faced by the industry; These kind of discussions bring more clarity among scientists, students and public at large.
Dr. Mahesh Balghat, Biological E. Limited, Hyderabad
I liked the event and thought that this was a good approach to discussing the business and science surrounding biotechnology. The time duration was adequate and the interactive sessions in the evening were informative.
Dr. Janakiraman Ramachandran, Chairman, Gangagen Inc, Bangalore
I enjoyed all the sessions I was able to attend. The exhibits were quite informative and the arrangements were excellent. Overall BIOASIA 2010 was a great success and I am very glad I could participate and contribute.
Prof. Marc Van Montagu, Founder Chairman, Institute of Plant Biotechnology in Developing Countries, Belgium
"It surely was very stimulating to meet so many excellent Indian colleagues and to see how motivated they are developing to Bio-Business. I noticed that BioAsia 09, attracted many SME's from the healthcare sector. For them high value chemicals from medicinal plants, the development of neutraceuticals and the processing of medicinal plants, a well established tradition all over Asia, all are an opportunity for biotechnological innovation"
Dr. Martin Mackay, President, Pfizer Global Research & Development, USA
"I was much honored to be part of BioAsia 2009. It was a terrific event. I was impressed by the energy level in the room that evening. It was well attended and the audience was very engaged. The willingness of the participants to partner with us was exceptional and I am truly delighted by the number of great connections we made at BioAsia and throughout our visit. In addition, the follow up to the event has been superb"
Dr. John M Hyde, Chairman, Hyde Engineering & Consulting Inc., USA
"Thank you very much for the invitation to speak at and participate in BioAsia 2009. It was a great experience and I am very grateful for the opportunity" |
